Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/11/2004WO2003084988A3 Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
11/11/2004WO2003071859A3 Methods for increasing the amount of protein in potato tubers
11/11/2004WO2003070912A3 RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/11/2004WO2003070885A3 SHORT INTERFERING NUCLEIC ACID INHIBITION OF STEAROYL-CoA DESATURASE (SCD) GENE
11/11/2004WO2003070747A3 Insulin and igf-1 receptor agonists and antagonists
11/11/2004WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
11/11/2004WO2003040695A3 Protein knobs
11/11/2004WO2003038052A3 Nucleic acid-associated proteins
11/11/2004WO2003027239A3 Melanin-concentrating hormone receptor antagonist binding protein
11/11/2004WO2003012068A3 Novel fusion proteins and assays for molecular binding
11/11/2004WO2003012044A3 Hagfish cathelin-associated antimicrobial peptides and genes
11/11/2004WO2002070665A3 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/11/2004WO2002064764A8 Terpene synthase/cyclase and olefin synthase and uses thereof
11/11/2004US20040226059 Harvesting cereal plant microspore, inoculating nutrient broth, induction of propagation, modify embryo, regenerate plant; tissue engineering
11/11/2004US20040226058 Prolonged culturing of avian (chicken) primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians (chickens)
11/11/2004US20040226055 Animal model exhibiting pathological conditions of Alzheimer's disease
11/11/2004US20040226054 Monitoring effectiveness of anti-alzheimer agents via measurement of adjustments in synaptophysin gene expression; tissue engineering
11/11/2004US20040225119 Fluorescent dyes for use as diagnostic/signalling tool in nucleotide sequence analysis
11/11/2004US20040225118 31 human secreted proteins
11/11/2004US20040225114 IGF-1 receptor interacting proteins
11/11/2004US20040224915 High affinity vascular endothelial growth factor(VEGF) receptor nucleic acid ligands and inhibitors
11/11/2004US20040224914 Administering to an individual suffering from the non-cancerous angiogenesis-related disease an amount of a therapeutic formulation effective to reduce the effective amount of clusterin in the individual
11/11/2004US20040224913 Antisense oligomers
11/11/2004US20040224912 For therapy and prophylaxis of hyperproliferative disorder
11/11/2004US20040224911 Transporters and ion channels
11/11/2004US20040224910 Recombinant nematode nicotinic receptor and uses
11/11/2004US20040224909 For inhibiting proliferation of a human tumor cell
11/11/2004US20040224891 Methods for the early diagnosis of ovarian cancer
11/11/2004US20040224889 extracellular administration; antisense therapy
11/11/2004US20040224888 Use of cardiotrophin in liver diseases
11/11/2004US20040224885 Methods of treating hypertension and compositions for use therein
11/11/2004US20040224882 modulating cell growth, cell differentiation, or cell survival; genetic engineering using hedgehog genes and proteins; neurodegenerative diseases; tissue-targeted therapy
11/11/2004US20040224881 drug screening for chloride channel blockers; osteoporosis, osteolytic cancer, osteopetrosis, Paget's disease; anticarcinogenic agents
11/11/2004US20040224424 Nucleotide sequences comprising allelic variant of cytochrome p450 for use in diagnosis and treatment of cell proliferative, nervous system and cardiovascular disorders; pharmacodynamic profiles and drug screening
11/11/2004US20040224415 Method for modifying chromosomes
11/11/2004US20040224414 Transposon-based transformation system
11/11/2004US20040224413 Comprises nucleotide sequences coding desaturases for transformation and propagation in plants; for generation of plants with minimum possible saturated fatty acids in seeds; enhanced dietary sources; tissue engineering
11/11/2004US20040224412 Repressor-mediated regulation system for control of gene expression in plants
11/11/2004US20040224411 Transgenic cell comprising adenoviral vector for use as gene delivery tool; tissue engineering heterologous gene expression; DNA vaccines
11/11/2004US20040224410 DNA virus for use as transfection and protein expression tool in genetic engineering; bioreactors for screening protein folding activities; diagnosis and treatment of polypeptide misfolding disorders
11/11/2004US20040224409 Replication defective plasmid comprising nucleotide sequences coding nerve growth factor for use in the treatment and/or prevention of degenerative neurological diseases; tissue engineering and targeted therapy
11/11/2004US20040224407 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
11/11/2004US20040224405 Using RNA interference to control gene expression in cells; antisense agents and genetic suppressor elements; tissue targeted therapy and engineering
11/11/2004US20040224404 Conditionally replicating viral vectors and their use
11/11/2004US20040224400 Novel multifunctional adhesin proteins and their display in microbial cells
11/11/2004US20040224394 Transgenic cells, rapamycin biosynthetic cluster for use in production of compounds used as antifungals, neurophins, immunosuppressant and antitumor agents; bioreactors
11/11/2004US20040224393 Modified human granulocyte-colony stimulating factor and process for producing same
11/11/2004US20040224390 More stable analog of isopropylthiogalactoside for induction of protein expression
11/11/2004US20040224388 Hyphal growth in fungi
11/11/2004US20040224386 Protein tyrosine kinases
11/11/2004US20040224385 Zinc finger binding domains for cnn
11/11/2004US20040224383 Conversion of farnesyl pyrophosphate to cartenoids; genetic engineered Dna
11/11/2004US20040224378 Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs
11/11/2004US20040224363 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
11/11/2004US20040224358 identifying microbial peptides such as cercopins then screening combinatorial libraries; biochemical immobilization; solid phase synthesis
11/11/2004US20040224357 Nucleotide sequences coding salivary gland microbial polypeptide for use in diagnosis and treatment of digestive, endocrine and immune system disorder
11/11/2004US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004US20040224355 Using guanylate cyclase gene expression for imaging and treating primary and/or metastatic stomach or esophageal cancer; tissue targeted therapy; genetic vaccines; immunotherapy
11/11/2004US20040224354 Capillary comprising inlet and outlet, a plurality of particles inside and probes immobilized on particles; for use in forming biochip microarrays for genomic analysis and disease diagnosis
11/11/2004US20040224353 Nucleic acid detection methods using universal priming
11/11/2004US20040224352 Identifying single nucleotide polymorphisms in amplicons using probes which recognize and bind upstream and downstream primimg sites; genomic and genotyping
11/11/2004US20040224349 Methods of screening novel agents for use in cancer therapy and prevention
11/11/2004US20040224348 Two oligonucleotides for use in in vitro diagnostic detection of pathogenic bacteria; identifying microorganisms associated with opportunistic infections in immunocompromised individuals
11/11/2004US20040224346 Pool and superpool matrix coding and decoding designs and methods
11/11/2004US20040224344 Methods and compositions to extract DNA, RNA and protein simultaneously from biological samples
11/11/2004US20040224340 Displacing a plasmid in a bacterial population
11/11/2004US20040224335 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
11/11/2004US20040224328 Identifying regulatory binding sites of short interfering RNA; antisense agents and gene expression inhibition
11/11/2004US20040224323 PAK5 screening methods
11/11/2004US20040224321 Micro/nano-structures fabricated by laser ablation for micro-array applications
11/11/2004US20040224320 Method for efficiently determining a DNA strand break
11/11/2004US20040224314 G-protein coupled receptors
11/11/2004US20040224313 Comprises nucleotide sequences coding cytochrome p450 oxygenase variant for identifying modulator use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; antitumor agents
11/11/2004US20040224306 Monitoring therapeutic efficacy of chlorite mixture comprising three proinflammatory cytokine on treatment of viral, gastrointestinal, cardiovascular, inflammatory and autoimmue diseases
11/11/2004US20040224288 Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis
11/11/2004US20040223974 Vaccines, immunotherapeutics and methods for using the same
11/11/2004US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004US20040223965 Hepatitis b core antigen fusion proteins
11/11/2004US20040223961 Enzyme treatment
11/11/2004US20040223960 lipid hydrolyzing protein or polypeptide, particularly the protein lysosomal acid lipase; treating atherosclerosis, Wolman's Disease and Cholesteryl Ester Storage Disease
11/11/2004US20040223953 Combined adeno-associated virus and adenovirus cocktail gene delivery system for high efficiency gene expression without eliciting immune response in immuno-competent subjects
11/11/2004US20040222382 Devices incorporating soft ionization membrane
11/11/2004US20040222371 Soft ionization device and applications thereof
11/11/2004CA2528143A1 Method of diagnosing a genetic susceptibility for bone damage
11/11/2004CA2524360A1 Novel composition and methods for the treatment of immune disorders
11/11/2004CA2524270A1 Method for the production of an n-terminally modified chemotactic factor
11/11/2004CA2523912A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004CA2523875A1 Sars virus nucleotide and amino acid sequences and uses thereof
11/11/2004CA2523751A1 Array having substances fixed on support arranged with chromosomal order or sequence position information added thereto, process for producing the same, analytical system using the array and use of these
11/11/2004CA2523575A1 Genetic modification of targeted regions of the cardiac conduction system
11/11/2004CA2523539A1 Production of high mannose proteins in plant culture
11/11/2004CA2523537A1 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004CA2523501A1 Preservation of rna in a biological sample
11/11/2004CA2523413A1 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
11/11/2004CA2523402A1 Group 1 mite polypeptide variants
11/11/2004CA2523323A1 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
11/11/2004CA2523319A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
11/11/2004CA2523266A1 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
11/11/2004CA2523034A1 Method of producing target protein, fused protein and gene thereof, partial sequence protein of intein and gene thereof, expression vector and transformant
11/11/2004CA2523025A1 Spex compositions and methods of use